Medical Xpress October 24, 2024
Researchers have shown that they can accurately recreate clinical trials of new treatments using “digital twins” of real cancer patients. The technology, called FarrSight-Twin, which is based on algorithms used by astrophysicists to discover black holes, was presented at the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain.
The researchers say that this approach could be used by cancer researchers to run virtual clinical trials before testing new treatments on patients. It could also be used alongside clinical trials with a digital twin for each patient taking part, which together could form a control group for any trial. Ultimately, it might mean that patients could have different treatments tested on their digital twin to help select...
Today's Sponsors
Today's Sponsor